Healthcare -
Biotechnology - NASDAQ - US
$ 13.7
1.48 %
$ 623 M
Market Cap
-13.43
P/E
Price Target
Average
109.25%
Revenue Forecast
Estimate
125.27%
EBIT
Estimate
--127.98%
Net Income
Estimate
83.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Capricor Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CAPR of $28.7 , with forecasts ranging from
a
low of
$14 to a high of $43 .
CAPR Lowest Price Target
Wall Street Target
14 USD
2.19%
CAPR Average Price Target
Wall Street Target
28.7 USD
109.25%
CAPR Highest Price Target
Wall Street Target
43 USD
213.87%
REVENUE FORECAST
Revenue Forecast Chart CAPR
EBIT FORECAST
EBIT Forecast Chart CAPR
NET INCOME FORECAST
Net Income Chart CAPR